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Achondroplasia (ACH) is the most common form of hereditary dwarﬁsm and presents with multiple
musculoskeletal anomalies but is not normally associated with premature hip arthritis. Developmental
dysplasia of the hip (DDH) is a spectrum of disease resulting in shallow acetabular depth and a pro-
pensity for chronic femoral subluxation or dislocation; it is among the most common causes of pre-
mature arthritis. This case report describes the diagnosis of symptomatic DDH in a patient with ACH and
highlights difﬁculties of primary total hip arthroplasty (THA) as a treatment option. Intraoperative
radiographic imaging is advised to ensure proper prosthesis placement. Femoral osteotomy may aid
visualization, reduction, and avoidance of soft tissue injury. Concomitant ACH and DDH is a challenging
problem that can be successfully treated with modiﬁed THA.
Copyright © 2015 The Authors. Published by Elsevier Inc. on behalf of American Association of Hip and
Knee Surgeons. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).Introduction
Achondroplasia (ACH) is the most common form of hereditary
dwarﬁsm [1,2]. The incidence is estimated to range between 1 and
4.5/30,000 live births [2,3]. Achondroplasia is marked by numerous
changes in musculoskeletal anatomy and joint mechanics, but has
not been found to be a signiﬁcant cause of early hip degeneration
[4]. Features commonly associated with ACH include a long and
narrow trunk, shortened extremities, particularly along the prox-
imal (rhizomelic) segments, bowing of the tibia, and deepening and
ﬂattening of the acetabulum [5e7]. Joint laxity is common, most
frequently in the knee and shoulder, and manifests as progressive
hyperextension of the knees and chronic inferior dislocation of the
shoulder, respectively [8,9].
Developmental dysplasia of the hip (DDH) is also characterized
by aberrant joint laxity, encompassing a spectrum of pathology
culminating in shallow acetabular depth and a propensity for hipclosed potential or pertinent
ent, either direct or indirect,
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range between 1 and 5 per 1000 live births [10,11]. DDH is among
the leading causes of premature hip osteoarthritis [12]. The hip-
speciﬁc features of DDH are summarized by Crowe [13,14] and
Hartoﬁlakidis [15] (Table 1). Crowe described the range of sublux-
ation of the femoral head as extending from less than 50% (group I)
to greater than 100% (group IV) [13,14]. Hartoﬁlakidis described
three types of DDH, ranging from only mild acetabular dysplasia to
a severe dysplasia of the acetabulum and chronic dislocation of the
hip with a pseudo-articulation between the femur and a hollow in
the iliac wing [15].
Concomitant DDH in the patient with ACH is a rare occurrence.
Here, we present a case of a patient with ACH undergoing total hip
arthroplasty (THA) due to osteoarthritis secondary to Crowe IV
DDH.
Case history
A 36-year-old female with ACH and bilateral DDH was referred
for evaluation due to severe pain and discomfort in both hips
(Fig. 1). The pain had increased in severity for the past ﬁve months
and was greatly exacerbated by activity. As a result of her debili-
tating pain, the patient was unable to walk a distance of greater
than one block. She had tried anti-inﬂammatory medications,
ambulatory assistive devices, and low-impact exercises, for more
than 3 months, none of which had provided substantial painan Association of Hip and Knee Surgeons. This is an open access article under the CC
Table 1
Crowe and Hartoﬁlakidis staging of developmental dysplasia of the hips.
Classiﬁcation Description
Crowe [13,14]
I Femoral head subluxation <50% or proximal
displacement <10%a
II Femoral head subluxation between 50% and
75% or proximal displacement between 10%
and 15%a
III Femoral head subluxation between 75% and
100% or proximal displacement between
15% and 20%a
IV Femoral head subluxation >100% or proximal
displacement >20%a
Hartoﬁlakidis [15]
Dysplasia Femoral head exhibits chronic subluxation
but located within true acetabulum
Low disarticulation Femoral head articulates with false acetabulum
partially covering the true acetabulum. Inferior
of false acetabulum overlies superior lip of true
acetabulum
High disarticulation Femoral head articulates with a hollow of the
iliac wing superior and posterior to true acetabulum.
No direct contact between false and true acetabulum
a Proximal displacement calculated as distance between medial femoral
headeneck junction and the inferior margin of the acetabulum divided by the
height of the pelvis.
Figure 1. Anteroposterior pelvis view of 36-year-old female with achondroplasia and
high hip dislocation, Crowe group IV developmental dysplasia of the hip.
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ACH and bilateral DDH. Both her father and son have ACH; there
was no history of DDH among ﬁrst-degree relatives reported.
On examination, the patient measured 122 cm (4 ft, 0 in) in
height. She had an intact neuromuscular examination of bilateral
lower extremities. Examination of both hips demonstrated full
passive range of motion. There was signiﬁcant pain in both hips
upon passive internal and external rotation as well as with ﬂexion
greater than 90. Radiographic evaluation demonstrated chroni-
cally dislocated hips, with severe degenerative changes about the
hip joints bilaterally and pseudo-articulation with the iliac crests
consistent with a Crowe IV classiﬁcation (Fig. 1).
Treatment options were discussed with the patient, with the
recommendation being bilateral total hip arthroplasty (THA) in a
staged manner starting with the left hip, as it was the more
symptomatic side. Intraoperatively, the patient was placed in the
right lateral decubitus position and a posterior approach utilized.
The pseudocapsule was identiﬁed and tagged. The location of the
under developed native acetabulum was identiﬁed visually, veri-
ﬁed with intraoperative imaging, and reamed to accept a 40 mm
acetabular cup (Fig. 2). A 40 mm cup was impacted into place with
45 of abduction and 20 anteversion. Two screws were placed to
secure the cup. A 22 mm highly cross-linked polyethylene liner
was used. The proximal femur was identiﬁed and the femoral
canal established and reamed to 11 mm. A 4 cm segment of the
proximal femur was removed via a shortening subtrochanteric
osteotomy to enable reduction (Fig. 3). Prophylactic cables were
paced both on the proximal and distal segments to prevent frac-
ture propagation. A modular 11 mm stem was impacted into place
and a 22 mm head was used. The resected proximal femur was
halved and used as a sleeve over the osteotomy site and held with
a 2 mm cable. After reduction, the hip was found to be stable in all
planes.
The patient was admitted on the standard total joint replace-
ment pathway and discharged on the second postoperative day
with instructions to be partial weight bearing. The ﬁrst clinic visit
was at two weeks after surgery. By that time, the patient was
participating well with physical therapy. Radiologic and clinical
examination conﬁrmed a stable left hip with no evidence of
infection, loosening, periprosthetic fracture, subluxation, ordislocation (Fig. 4a and b). She was kept partial weight bearing on
the left hip. At six weeks, the patient was still participating in
physical therapy without difﬁculty or complication; she was
instructed to begin weight bearing as tolerated and received a
temporary lift for her right shoe to correct the 2 cm leg length
discrepancy resulting from left hip restoration. At three months,
the patient was ambulating without difﬁculty and had no com-
plaints at the left hip or thigh; all components were well seated,
without evidence of loosening, fracture, or wear. At this time, the
patient was scheduled for right primary THA, which was subse-
quently completed without any complications with a similar
protocol (Fig. 5).Discussion
In this case report we describe a patient concurrently affected
by two musculoskeletal disorders with signiﬁcantly different
pathogenesis.Achondroplasia
Achondroplasia results from a fully penetrant, autosomal
dominant disorder of ﬁbroblast growth factor receptor-3 (FGFR3),
phenotypically characterized by sequela of deﬁcient endochondral
ossiﬁcation [16]. More than 95% of cases are thought to stem from
a gain of function Gly380Arg amino acid substitution in the
transmembrane domain of FGFR3 [16]. FGFR3 has been shown to
inhibit chondrocyte differentiation and proliferation largely
through its effects on MAPK and Stat1 signaling pathways,
respectively [17e19]. Effects of chondrocyte inhibition via FGFR3
are enacted at the physeal plate which are characteristically
delayed in maturation and thin until at least the age of puberty
[20,21].
Anatomic features of ACH persisting into adulthood include
rhizomelic short stature, frontal bossing of the skull, spinal stenosis,
pronounced lumbosacral lordosis, shortened lumbar pedicles,
ﬂared and splayed metaphysis, and joint laxity [5,22]. Pelvis- and
hip-speciﬁc characteristics of ACH include a shortened and broad-
ened pelvic cavity leading to a “champagne-glass” pelvis, squaring
of the iliac wings, a ﬂattened acetabular roof, a decreased acetab-
ular beta-angle, increased acetabular coverage of the femoral head,
genu varum, and a short and broad femoral neck [6,7].
Figure 2. Intraoperative radiograph of the pelvis with an acetabular reamer placed in
the underdeveloped native acetabulum prior to acetabular reaming.
Figure 3. 4 cm of subtrochanteric femur resection. Solid black lines demarcate 1 cm
intervals. Dashed black lines demarcate 1 in intervals.
T.L. Malcolm et al. / Arthroplasty Today 1 (2015) 111e115 113Despite aberrant joint mechanics, premature osteoarthritis is
only infrequently associated with ACH [4]. Musculoskeletal com-
plaints are common, but most often of spinous etiology [23]. End-
stage hip disease has been described in the literature for ACH
patients [24]. Chiavetta et al. described 37 patients that were short
in stature, four of whom had ACH, that underwent 62 THAs sec-
ondary to osteochondrodysplasia [24]. However, no comments
were made that addressed the uniqueness of ACH patients in this
study. The authors did note that DDHwas present in 18 hips but did
not comment if it was present among the ACH patients [24].
Developmental dysplasia of the hip
DDH is most commonly associated with decreased appositional
force between the femoral head and the acetabulum [25,26]. Risk
factors for DDH include joint laxity, female gender, large birth
weight for gestational age, breach delivery, oligohydramnios, and
infant swaddling [27e30]. While genetic determinants are poorly
described, multiple authors have found an increased risk associated
among family members harboring this disorder [31,32]. Lee et al.found more than half of patients diagnosed with DDH had a ﬁrst-
degree family member with DDH [31]. Kramer et al. reported that
for those affected with DDH, the odds of having a mother with DDH
was higher than a sibling or father [32].
While DDH may be related to underlying systemic ligamentous
laxity, DDH is a disorder localized to the hip joint. Whereas the
pelvis is grossly normal, the hip is dysplastic. The acetabulum is
shallow with deﬁciencies typically anterolaterally and superiorly.
The femur often demonstrates increased anteversion, a shorter
neck, decreased intramedullary canal size, and coxa vara or valga
angulation [33]. Among adults with DDH, there is a range of
dysplastic features and associated subluxation/dislocation.
DDH signiﬁcantly increases the risk of premature osteoar-
thritis [12,34]. Engesaeter et al. found that DDH increased by 2.6
fold the risk of undergoing total hip arthroplasty (THA) in pa-
tients under the age of 37 years old [34]. DDH is estimated to be
account for as much as 30% of adult total hip arthroplasty [12].
Hartoﬁlakidis et al. described the natural history of 202 hips
affected by DDH [15]. Three stages of arthritic disease progres-
sion were described: I: abnormal obliquity of the weight-bearing
surface of the acetabulum with a normal femoral head; II: nar-
rowed articular space with an elliptical femoral head and pro-
gressive subluxation; III: advanced degenerative arthritic
changes of the hip with large cysts and osteophytes of both the
acetabulum and femoral head and further subluxation of the
femoral head [15]. The rate of disease progression was found to
be dependent on baseline subluxation/dislocation. Patients with
chronic dislocation since childhood, on average, underwent THA
by the age of 48.8 [15].
Current controversies and future considerations
Common comorbidities seen in patients with ACH must be
addressed preoperatively to ensure a safe outcome. Craniofa-
cial deformities can increase the difﬁculty of mask ventilation
and intubation; however, a resultant increase in airway com-
plications has not been reported [35]. The spine and related
neurologic causes of pain should always be addressed prior to
Figure 4. (a) Anteroposterior and (b) lateral x rays of the left hip two weeks after surgery.
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is reported to be 40% narrower among those with ACH than
those without, despite preservation of the size of the spinal
cord and associated nerves [36].Figure 5. Standing anteroposterior x-ray of the pelvis at the 3-month postoperative visit.Detailed preoperative planning and intraoperative radio-
graphic imaging are important due to the anatomical changes
caused by ACH. The surgeon should verify during preoperative
planning that the femoral implant will successfully engage the
proximal femur and the distal femur segments as well as suc-
cessfully engage the femoral bow. In a study of THA in 62 pa-
tients with varying causes of dwarﬁsm, almost a quarter of
femoral components were found to be in a suboptimal position
thus potentially contributing to the high rate of revision THA (i.e.,
29%) reported in this study [24]. In addition, acetabular diameter
size may be extremely small in ACH patients, and the surgeon
should be prepared with proper acetabular implants.
The surgical challenges of DDH Crowe type 4 include severe
proximal femoral migration and chronic contraction of soft tis-
sues traversing the hip joint [37]. In cases whereby restoration of
the hip center to the true acetabulum may increase the length of
the operative limb by 4 cm or more, a subtrochanteric osteotomy
is advised [37]. After the subtrochanteric osteotomy is
completed, the remaining femoral shaft may limit the surgeon in
relation to stem type and length. Other surgical challenges of
DDH include hypoplasia and exaggerated anteversion of the ac-
etabulum, and narrowing of the femoral canal [37]. These chal-
lenges are accentuated in the achondroplastic patient, with
changes in acetabular size and femoral shaft length and diameter.
Intraoperative imaging should be used as required to locate the
native acetabulum and to ensure accurate restoration of the hip
joint.
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Developmental hip dysplasia in the patient with achondroplasia
is a rare and challenging condition. Primary total hip arthroplasty is
complicated by the chronic anatomical changes and standard sur-
gical landmarks may be altered or absent. This case report illus-
trates the difﬁculties of treating Crowe IV DDH in a person with
ACH, the importance of preoperative evaluation and planning, and
the techniques used to optimize a successful outcome.KEY POINTS
 A subtrochanteric osteotomy is advised if reduction of the
operative leg will increase its length by 4 cm or more, in order
to avoid sciatic nerve neuropathy.
 Standard surgical landmarks may be altered or absent in
patients with Crowe IV DDH. A concomitant diagnosis of ACH
adds another layer of difﬁculty to these cases.
 Proper preoperative planning and templating is imperative
due to the short stature and challenging anatomy of patients
with ACH and DDH.References
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